{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:42:26Z","timestamp":1776883346225,"version":"3.51.2"},"reference-count":47,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioral Sciences"],"abstract":"<jats:p>Criminal justice system (CJS) involvement is common among individuals with opioid use disorder (OUD), yet limited research examines retention in medications for OUD (MOUD) within community settings. This study assessed whether CJS involvement predicted retention on buprenorphine\/naloxone and explored related demographic and clinical factors. A retrospective cohort included adults (n = 367) enrolled in a low-barrier outpatient MOUD program in Texas (January 2022\u2013April 2024). CJS involvement was identified from program records. Retention was measured as the number of continuous days with buprenorphine\/naloxone prescriptions. Analyses used univariate tests, logistic regression, and nonparametric kernel regression. Nearly one-quarter (24.8%) were CJS-involved. Retention at 180 days was similar between CJS and non-CJS groups (38%). CJS participants initiated substance use earlier and reported higher heroin and injection drug use. Behavioral health sessions were associated with both CJS involvement (OR = 1.10, p \u2264 0.001) and longer retention (\u03b2 = 10.81 days\/session, p = 0.001). With comprehensive, low-barrier services, individuals involved with CJS achieved MOUD retention comparable to their peers. Early behavioral health engagement was a strong predictor of retention, suggesting a key intervention point to enhance outcomes and advance equity for justice-involved populations.<\/jats:p>","DOI":"10.3390\/bs16010122","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:13:21Z","timestamp":1768475601000},"page":"122","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retention on Buprenorphine for Opioid Use Disorder in Justice-Involved Individuals: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4300-9892","authenticated-orcid":false,"given":"Andrea","family":"Yatsco","sequence":"first","affiliation":[{"name":"Center for Behavioral Emergency & Addiction Research, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center, 7000 Fannin Street, Ste 600, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7914-0070","authenticated-orcid":false,"given":"Francine R.","family":"Vega","sequence":"additional","affiliation":[{"name":"Center for Behavioral Emergency & Addiction Research, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center, 7000 Fannin Street, Ste 600, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5513-831X","authenticated-orcid":false,"given":"Audrey Sarah","family":"Cohen","sequence":"additional","affiliation":[{"name":"Center for Behavioral Emergency & Addiction Research, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center, 7000 Fannin Street, Ste 600, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1834-3696","authenticated-orcid":false,"given":"Marylou","family":"Cardenas-Turanzas","sequence":"additional","affiliation":[{"name":"Center for Behavioral Emergency & Addiction Research, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center, 7000 Fannin Street, Ste 600, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-4853","authenticated-orcid":false,"given":"James R.","family":"Langabeer","sequence":"additional","affiliation":[{"name":"Center for Behavioral Emergency & Addiction Research, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center, 7000 Fannin Street, Ste 600, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4186-9648","authenticated-orcid":false,"given":"Tiffany","family":"Champagne-Langabeer","sequence":"additional","affiliation":[{"name":"Center for Behavioral Emergency & Addiction Research, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center, 7000 Fannin Street, Ste 600, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1176\/appi.ps.201900309","article-title":"Early discontinuation of buprenorphine therapy for opioid use disorder among privately insured adults","volume":"71","author":"Agbese","year":"2020","journal-title":"Psychiatric Services"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40352-022-00188-4","article-title":"Barriers to medications for opioid use disorder in the court system: Provider availability, provider \u201ctrustworthiness,\u201d and cost","volume":"10","author":"Ahmed","year":"2022","journal-title":"Health Justice"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/add.13200","article-title":"Clinical risk factors for death after release from prison in Washington state: A nested case-control study","volume":"111","author":"Binswanger","year":"2016","journal-title":"Addiction"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"209051","DOI":"10.1016\/j.josat.2023.209051","article-title":"Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians","volume":"149","author":"Booty","year":"2023","journal-title":"Journal of Substance Use & Addiction Treatment"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e242732","DOI":"10.1001\/jamanetworkopen.2024.2732","article-title":"Prison buprenorphine implementation and postrelease opioid use disorder outcomes","volume":"7","author":"Yan","year":"2024","journal-title":"JAMA Network Open"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3982\/ECTA12701","article-title":"Kernel-based semiparametric estimators: Small bandwidth asymptotics and bootstrap consistency","volume":"86","author":"Cattaneo","year":"2018","journal-title":"Econometrica"},{"key":"ref_7","unstructured":"Centers for Medicare and Medicaid (2025, August 04). Quality ID #468: Continuity of pharmacotherapy for opioid use disorder (OUD) (MIPS clinical quality measures (CQMS)), Available online: https:\/\/qpp.cms.gov\/docs\/QPP_quality_measure_specifications\/CQM-Measures\/2025_Measure_468_MIPSCQM.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Current Opinion Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jsat.2012.10.003","article-title":"Does mandating offenders to treatment improve completion rates?","volume":"44","author":"Coviello","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100508","DOI":"10.1016\/j.ijlcj.2021.100508","article-title":"The legitimacy of criminalizing drugs: Applying the \u2018harm principle\u2019 of John Stuart Mill to contemporary decision-making","volume":"68","author":"Debbaut","year":"2022","journal-title":"International Journal of Law, Crime and Justice"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/00333549231222479","article-title":"The medications for opioid use disorder study: Methods and initial outcomes from an 18-month study of patients in treatment for opioid use disorder","volume":"139","author":"Dever","year":"2024","journal-title":"Public Health Reports"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2016.01.013","article-title":"Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. veterans health administration patients","volume":"160","author":"Finlay","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108350","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112525","DOI":"10.1016\/j.drugalcdep.2024.112525","article-title":"Beyond the first try: How many quit attempts are necessary to achieve substance use cessation?","volume":"267","author":"Fontes","year":"2025","journal-title":"Drug and Alcohol Dependence"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13011-021-00346-1","article-title":"A scoping review of factors that influence opioid overdose prevention for justice-involved populations","volume":"16","author":"Grella","year":"2021","journal-title":"Substance Abuse Treatment, Prevention, Policy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/10826084.2022.2034869","article-title":"Opioid agonist treatment recipients within criminal justice-involved populations","volume":"57","author":"Guastaferro","year":"2022","journal-title":"Substance Use & Misuse"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hachtel, H., Vogel, T., and Huber, C. G. (2019). Mandated treatment and its impact on therapeutic process and outcome factors. Frontiers in Psychiatry, 10.","DOI":"10.3389\/fpsyt.2019.00219"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"108416","DOI":"10.1016\/j.jsat.2021.108416","article-title":"Patterns of patient discontinuation from buprenorphine\/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts","volume":"131","author":"Hasan","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/29767342251341709","article-title":"A buprenorphine retention report to measure opioid use disorder care metrics and guide outreach","volume":"47","author":"Hazelton","year":"2025","journal-title":"Substance Use & Addiction Journal"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12245-024-00593-6","article-title":"Overview of best practices for buprenorphine initiation in the emergency department","volume":"17","author":"Hughes","year":"2024","journal-title":"International Journal of Emergency Medicine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11606-020-06448-z","article-title":"Factors associated with long-term retention in buprenorphine-based addiction treatment programs: A systematic review","volume":"37","author":"Kennedy","year":"2022","journal-title":"Journal of General Internal Medicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/ADM.0b013e3182312983","article-title":"Statement of the american society of addiction medicine consensus panel on the use of buprenorphine in office-based treatment of opioid addiction","volume":"5","author":"Kraus","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Affairs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"108329","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings","volume":"126","author":"Krawczyk","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e12417","DOI":"10.1002\/emp2.12417","article-title":"Feasibility and outcomes from an integrated bridge treatment program for opioid use disorder","volume":"2","author":"Langabeer","year":"2021","journal-title":"Journal of The American College of Emergency Physicians Open"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Langabeer, J. R., Vega, F. R., Cardenas-Turanzas, M., Cohen, A. S., Lalani, K., and Champagne-Langabeer, T. (2024). How financial beliefs and behaviors influence the financial health of individuals struggling with opioid use disorder. Behavioral Sciences, 14, (5).","DOI":"10.3390\/bs14050394"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/10485250310001605450","article-title":"Multivariate local polynomial regression for estimating average derivatives","volume":"15","author":"Li","year":"2003","journal-title":"Journal of Nonparametric Statistics"},{"key":"ref_28","first-page":"485","article-title":"Cross-validated local linear nonparametric regression","volume":"14","author":"Li","year":"2004","journal-title":"Statistica Sinica"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","article-title":"Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review","volume":"99","author":"Moore","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"ref_30","unstructured":"National Academies of Sciences, Engineering, and Medicine (2019). Medications for opioid use disorder save lives, The National Academies Press."},{"key":"ref_31","unstructured":"National Alliance of Advocates for Buprenorphine Treatment [NAABT] (2025, August 04). Dosing guide for optimal management of opioid dependence: Dosing guidance for SUBOXONE\u00ae & SUBUTEX\u00ae [PDF], Available online: https:\/\/www.naabt.org\/documents\/Suboxone_dosing_guide.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"208950","DOI":"10.1016\/j.josat.2022.208950","article-title":"Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers","volume":"147","author":"Pivovarova","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1345\/aph.10421","article-title":"Opioid dependence treatment, including buprenorphine\/naloxone","volume":"36","author":"Raisch","year":"2002","journal-title":"The Annals of Pharmacotherapy"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"108423","DOI":"10.1016\/j.jsat.2021.108423","article-title":"Utilization of substance use treatment among criminal justice-involved individuals in the United States","volume":"125","author":"Bellerose","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"109498","DOI":"10.1016\/j.drugalcdep.2022.109498","article-title":"Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015\u20132018","volume":"236","author":"Stahler","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"ref_37","unstructured":"(2017). Stata statistical software (Release 15), Stata Corp LLC."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/jcop.23029","article-title":"Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice-involved individuals in rural Appalachia","volume":"52","author":"Staton","year":"2023","journal-title":"Journal of Community Psychology"},{"key":"ref_39","unstructured":"Substance Abuse and Mental Health Services Administration [SAMHSA] (2021). Medications for opioid use disorder (Treatment Improvement Protocol [TIP] Series 63; No. PEP21-02-01-002)."},{"key":"ref_40","unstructured":"Substance Abuse and Mental Health Services Administration [SAMHSA] (2024, November 06). Waiver elimination (MAT act), Available online: https:\/\/www.samhsa.gov\/substance-use\/treatment\/statutes-regulations-guidelines\/mat-act."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcrimjus.2016.05.002","article-title":"Changes in inmates\u2019 substance use and dependence from pre-incarceration to one year post-release","volume":"46","author":"Tangney","year":"2016","journal-title":"Journal of Criminal Justice"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addiction Diseases"},{"key":"ref_43","unstructured":"U.S. Food and Drug Administration [FDA] (2025, August 04). Suboxone (buprenorphine and naloxone) sublingual tablets: Label (prescribing information) [PDF], Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020733s007s008lbl.pdf."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102849","DOI":"10.1016\/j.drugpo.2020.102849","article-title":"Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives","volume":"83","author":"Yatsco","year":"2020a","journal-title":"International Journal of Drug Policy"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1178221820953390","DOI":"10.1177\/1178221820953390","article-title":"Alternatives to arrest for illicit opioid use: A joint criminal justice and healthcare treatment collaboration","volume":"14","author":"Yatsco","year":"2020b","journal-title":"Substance Abuse Research and Treatment"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"108686","DOI":"10.1016\/j.jsat.2021.108686","article-title":"Examining differences in retention on medication for opioid use disorder: An analysis of Ohio medicaid data","volume":"136","author":"Zhang","year":"2022","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Behavioral Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-328X\/16\/1\/122\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:18:36Z","timestamp":1768479516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-328X\/16\/1\/122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["bs16010122"],"URL":"https:\/\/doi.org\/10.3390\/bs16010122","relation":{},"ISSN":["2076-328X"],"issn-type":[{"value":"2076-328X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}